Compare Huntington Bancshares Incorporated (HBAN) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Bancshares Incorporated vs Nuvalent Inc — how do they compare? Huntington Bancshares Incorporated trades at $18.13 (market cap $36.62B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: Huntington Bancshares Incorporated is far larger — about 3.7× Nuvalent Inc's market cap, and Huntington Bancshares Incorporated pays a 3.43% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| HBAN | NUVL | |
|---|---|---|
Market Cap | $36.62B | $9.81B |
Sector | Financials | Technology |
52-Week High | $19.27 | $123.96 |
52-Week Low | $15.02 | $72.16 |
Dividend Yield | 3.43% | — |
Enterprise Value | — | $8.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
